Medical Device Contract Manufacturing Market to Grow from USD 83.77 Billion in 2025 to USD 140.84 Billion by 2030, at a CAGR of 10.9% – MarketsandMarkets™

Delray Beach, FL, Aug. 14, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global medical device contract manufacturing market will grow from USD 83.77 billion in 2025 to USD 140.84 billion by 2030, at a CAGR of 10.9% during the forecast period. Market growth is fueled by rising demand for complex and small-scale medical devices, particularly in diagnostic imaging, wearable health technology, and minimally invasive procedures, along with increasing healthcare costs and regulatory demands that are encouraging OEMs to outsource production to specialized contract manufacturers to reduce operational expenses and accelerate time-to-market.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851

Key Market Highlights

• Market size, 2025: USD 83.77 billion
• Market forecast, 2030: USD 140.84 billion
• Growth rate: CAGR of 10.9% (2025–2030)
• Largest regional market: Asia Pacific
• Largest device type segment: IVD devices
• Largest service segment: Packaging & assembly services
• Largest class of device segment: Class III medical devices
• Fastest-growing class of device segment: Class III medical devices
• Key players: Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), Integer Holdings Corporation (US), TE Connectivity Ltd. (Switzerland), Nipro Corporation (Japan), Celestica Inc. (Canada), West Pharmaceutical Services, Inc. (US), Benchmark Electronics Inc. (US), Recipharm AB (Sweden), Gerresheimer AG (Germany), Kimball Electronics Inc. (US), Nortech Systems, Inc. (US), Carclo Plc (UK), Nolato GW, Inc. (US), Nemera Development S.A. (France), Viant Medical Holdings, Inc. (US), Tecomet, Inc. (US), SMC Ltd. (US), Phillips-Medisize Corporation (US), Tessy Plastics Corp. (US), MeHow (China), Tekni-Plex (US), and Peter's Technology (China).

Why This Market Matters

The medical device contract manufacturing market is benefiting from growing demand for complex and small-scale medical devices, particularly across diagnostic imaging, wearable health technology, and minimally invasive procedures. OEMs are increasingly outsourcing production to specialized contract manufacturers with the expertise and infrastructure required to support these technologies. Rising healthcare costs and regulatory requirements are also encouraging companies to reduce operational expenses and accelerate time-to-market through outsourcing.

The rising aging population is another major factor supporting market growth. According to United Nations projections cited in the report, the global population aged 60 and over is expected to nearly double from 1 billion in 2020 to 2.1 billion by 2050. The growing older population is associated with increasing demand for healthcare services, continuous medical care, monitoring, implantables, diagnostic equipment, and home healthcare technologies.

Market Overview

The medical device contract manufacturing market is witnessing strong growth as manufacturers respond to increasing demand for high-performance, miniaturized, and digitally integrated medical devices. Adoption of robotics and automation, technological advancements in medical device modalities, and the impact of Industry 4.0 are supporting the development of advanced manufacturing capabilities.

The market ecosystem includes product manufacturers and regulatory bodies. Contract manufacturers support OEMs through specialized manufacturing, engineering, supply chain, quality, packaging, assembly, and other services, while regulatory bodies such as the FDA and EMA establish requirements related to product safety, efficacy, quality control, and documentation.

Analyst Perspective

The medical device contract manufacturing industry is increasingly focused on balancing technological capabilities with manufacturing costs. Demand for high-performance, miniaturized, and digitally integrated devices is driving investment in automation, robotics, additive manufacturing, and advanced materials. However, the capital-intensive nature of these technologies can create challenges for smaller and mid-sized contract manufacturers, highlighting the importance of strategic partnerships, investment in innovation, and collaborative manufacturing models.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=170622851

Segment Analysis

By device type, IVD devices are the largest segment of the medical device contract manufacturing market. IVD tests can deliver results in minutes or hours compared with traditional methods that may take days or weeks, which is expected to support segment growth.

By class of device, the market is segmented into Class I, Class II, and Class III devices. Class III is expected to show the highest CAGR from 2025 to 2030. The report also identifies Class III as the largest segment by class of device, with the greater reliability and effectiveness of these devices compared with lower classifications supporting segment growth.

By service, the market is segmented into device development and manufacturing services, quality management services, packaging & assembly services, and other services. Packaging & assembly services hold the largest share, as effective packaging and assembly processes are fundamental to ensuring the safety and efficacy of medical devices.

Regional Analysis

Asia Pacific accounted for the largest share of the global medical device contract manufacturing market in 2024. The region is supported by increasing technological advancements, a growing geriatric population, rising awareness and prevalence of chronic diseases, and increasing healthcare demand. The report also identifies China as having the largest market share in 2024 and as the fastest-growing country in the region.

North America held a 21.4% share of the medical device contract manufacturing market in 2024. Growth in the region is supported by the growing medical devices market in emerging economies, adoption of robotics and automation in manufacturing, technological advancements in medical device modalities, and the impact of Industry 4.0 on the medical device industry.

Key Industry Trends

• Growing medical devices market in emerging economies
• Adoption of robotics and automation in manufacturing
• Technological advancements in medical device modalities
• Increasing impact of Industry 4.0 on the medical device industry
• Rising demand for complex and small-scale medical devices
• Growing outsourcing of medical device production by OEMs
• Increasing demand for high-performance, miniaturized, and digitally integrated devices
• Growing use of advanced technologies such as additive manufacturing and smart materials.

Competitive Landscape

The competitive landscape of the medical device contract manufacturing market is highly fragmented. The top five players-Jabil Inc., Flex Ltd., Integer Holdings Corporation, Plexus Corp., and Sanmina Corporation-collectively hold approximately 15.0% to 20.0% of the global market share. Jabil Inc. is supported by extensive global production capabilities and comprehensive solutions spanning design to regulatory-compliant manufacturing for Class II and III devices. Flex provides advanced manufacturing ecosystems and digital supply chain capabilities, while Plexus focuses on product development and regulatory compliance. Sanmina provides electronic systems integration and turnkey solutions, and Integer Holdings Corporation offers vertically integrated manufacturing and R&D capabilities in interventional, cardiovascular, and neuromodulation markets.

Key players have adopted acquisitions and expansions as dominant growth strategies. In May 2025, Flex Ltd. expanded its partnership with Arch Systems to optimize manufacturing operations through advanced data and analytics-driven insights. In February 2025, Jabil Inc. acquired Pharmaceutics International, Inc., while Integer Holdings Corporation acquired Precision Coating for USD 152 million.

Related Reports
Pharmaceutical Contract Manufacturing Market
Diagnostic Contract Manufacturing Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Report Code: MD 7111 | Published: 9 July 2025 | Report Pages: 420 | Market Data Tables: 65 | Figures: 68